MedPath

RHEUMALAN ONT

RHEUMALAN ONT

Discontinued
DIN Number

00398969

Drug Class

Human

Market Date

Dec 31, 1957

Company
HC

hilary's distibution ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00398969
AIG Number0911957001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
M02AC PREPARATIONS WITH SALICYLIC ACID DERIVATIVES
Product Specifications
Dosage FormOintment
Route of AdministrationTopical
AHFS Classification28:08.04.24
Health Canada Classification

ACTIVE INGREDIENTS (9)

BELLADONNAActive
Strength: 628 MG / 28.3 G
Monograph: BELLADONNA
CAMPHORActive
Strength: 383 MG / 28.3 G
Monograph: CAMPHOR
CAPSICUM OLEORESINActive
Strength: 295 MG / 28.3 G
Monograph: CAPSICUM OLEORESIN
CROTON OILActive
Strength: 55 MG / 28.3 G
Monograph: CROTON OIL
EUCALYPTUS OILActive
Strength: 237 MG / 28.3 G
Monograph: EUCALYPTUS OIL
MENTHOLActive
Strength: 602 MG / 28.3 G
Monograph: MENTHOL
METHYL SALICYLATEActive
Strength: 3.786 G / 28.3 G
Monograph: METHYL SALICYLATE
OIL OF MUSTARD EXPRESSEDActive
Strength: 53 MG / 28.3 G
Monograph: OIL OF MUSTARD EXPRESSED
SALICYLIC ACIDActive
Strength: 134 MG / 28.3 G
Monograph: SALICYLIC ACID

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.